Pathogenesis of ANCA-associated vasculitis: New possibilities for intervention

American Journal of Kidney Diseases

Volumn 62, Issue 6, 2013, Pages 1176-1187

  Kallenberg, Cees G M ^a   Stegeman, Coen A ^a   Abdulahad, Wayel H ^a   Heeringa, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

antibodies to myeloperoxidase (MPO ANCA); antibodies to proteinase 3 (PR3 ANCA); Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis; granulomatosis with polyangiitis (GPA); microscopic polyangiitis (MPA); pathogenesis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; DOXYCYCLINE; ENALAPRIL; HEMOGLOBIN; LACTATE DEHYDROGENASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; POTASSIUM; PREDNISOLONE; SODIUM; HLA ANTIGEN CLASS 2; MYELOBLASTIN; PEROXIDASE; SILICON DIOXIDE;

ACANTHOCYTOSIS; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CASE REPORT; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPISTAXIS; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GLOMERULUS FILTRATION RATE; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY BIOPSY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MALAISE; MALE; NIGHT SWEAT; NOSE OBSTRUCTION; PATIENT REFERRAL; PERONEUS NERVE PARALYSIS; PLASMAPHERESIS; POTASSIUM BLOOD LEVEL; PROTEINURIA; PURPURA; RESPIRATORY TRACT INFECTION; SMELLING DISORDER; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; URINE SEDIMENT; WEIGHT REDUCTION; CHURG STRAUSS SYNDROME; COMPLEMENT ALTERNATIVE PATHWAY; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; GLOMERULONEPHRITIS; IMMUNOLOGY; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHURG-STRAUSS SYNDROME; COMPLEMENT PATHWAY, ALTERNATIVE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICROSCOPIC POLYANGIITIS; MYELOBLASTIN; PEROXIDASE; POLYARTERITIS NODOSA; SILICON DIOXIDE; STAPHYLOCOCCAL INFECTIONS; T-LYMPHOCYTES;

EID: 84888376081     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.05.009     Document Type: Article

References (103)

1. J. Jennette, R. Falk, and P. Bacon 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum 65 2013 1 11
2. R.A. Luqmani, R. Suppiah, and P.C. Grayson Nomenclature and classification of vasculitis - update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS) Clin Exp Immunol 164 suppl 1 2011 11 13
3. G.S. Hoffman, and U. Specks Antineutrophil cytoplasmic antibodies Arthritis Rheum 41 1998 1521 1537 (Pubitemid 28459910)
4. M. Chen, and C.G. Kallenberg ANCA-associated vasculitides - advances in pathogenesis and treatment Nat Rev Rheumatol 6 2010 653 664
5. C.G. Kallenberg Churg-Strauss syndrome: just one disease entity? Arthritis Rheum 52 2005 2589 2593 (Pubitemid 41369085)
6. J.D. Finkielman, A.S. Lee, and A.M. Hummel ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis Am J Med 120 2007 643.e9 643.e14
7. M. Chen, C.G. Kallenberg, and M.H. Zhao ANCA-negative pauci-immune crescentic glomerulonephritis Nat Rev Nephrol 5 2009 313 318
8. M.M. Boomsma, C.A. Stegeman, and M.J. van der Leij Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasma antibody levels: a prospective study Arthritis Rheum 43 2000 2025 2033
9. G. Tomasson, P.C. Grayson, and A.D. Mahr Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis - a meta-analysis Rheumatology (Oxford) 51 2012 100 109
10. R. Cartin-Ceba, J.M. Golbin, and K.A. Keogh Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center Arthritis Rheum 64 2012 3770 3778
11. C.F. Franssen, C.A. Stegeman, and C.G. Kallenberg Antiproteinase 3- and antimyeloperoxidase-associated vasculitis Kidney Int 57 2000 2195 2206 (Pubitemid 30340718)
12. M. Walsh, O. Flossmann, and A. Berden Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 64 2012 542 548
13. P.A. Lyons, T.F. Rayner, and S. Trivedi Genetically distinct subsets within ANCA-associated vasculitis N Engl J Med 367 2012 214 223
14. P.J. Bansal, and M.C. Tobin Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement Ann Allergy Asthma Immunol 93 2004 398 401 (Pubitemid 39382982)
15. F. Silva, U. Specks, and S. Sethi Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis Am J Kidney Dis 54 2009 542 545
16. B.F. Bruner, E.S. Vista, D.M. Wynn, and J.A. James Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes Clin Exp Immunol 164 2011 330 336
17. B.F. Bruner, E.S. Vista, and D.M. Wynn Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener's granulomatosis Clin Exp Immunol 162 2010 262 270
18. A.J. Roth, J.D. Ooi, and J.J. Hess Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis J Clin Invest 123 2013 1773 1783
19. C. Espy, W. Morelle, and N. Kavian Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's) Arthritis Rheum 63 2011 2105 2115
20. E. Brouwer, M.G. Huitema, and P.A. Klok Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model J Exp Med 177 1993 905 914 (Pubitemid 23097380)
21. P. Heeringa, E. Brouwer, and P.A. Klok Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat Am J Pathol 149 1996 1695 1706 (Pubitemid 26363975)
22. H. Xiao, P. Heeringa, and P. Hu Antineutrophil cytoplasmic antibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice J Clin Invest 110 2002 955 963
23. D. Huugen, H. Xiao, and A. van Esch Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha Am J Pathol 167 2005 47 58 (Pubitemid 40884769)
24. H. Xiao, A. Schreiber, and P. Heeringa Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies Am J Pathol 170 2007 52 64 (Pubitemid 47339189)
25. D. Huugen, A. van Esch, and H. Xiao Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice Kidney Int 71 2007 646 654 (Pubitemid 46494558)
26. S.J. Gou, J. Yuan, and M. Chen Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis Kidney Int 83 2013 129 137
27. G.Q. Xing, M. Chen, and G. Liu Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis J Clin Immunol 29 2009 282 291
28. M.A. Little, C.L. Smyth, and R. Yadao Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo Blood 106 2005 2050 2058 (Pubitemid 41291719)
29. S.L. Nolan, N. Kalia, and G.B. Nash Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo J Am Soc Nephrol 19 2008 973 984
30. A.J. Ruth, A.R. Kitching, and R.I. Kwan Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis J Am Soc Nephrol 17 2006 1940 1949 (Pubitemid 44036178)
31. P.I. Gan, O.M. Steinmetz, and D.S. Tan Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis J Am Soc Nephrol 21 2010 925 931
32. J.D. Ooi, J. Chang, and M.J. Hickey The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis Proc Natl Acad Sci U S A 109 2012 E2615 E2624
33. H. Pfister, M. Ollert, and L.F. Fröhlich Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo Blood 104 2004 1411 1418 (Pubitemid 39166519)
34. Y.M. Van der Geld, T. Hellmark, and D. Selga Rats and mice immunized with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes Ann Rheum Dis 66 2007 1679 1682 (Pubitemid 350205462)
35. M.A. Little, B. Al-Ani, and S. Ren Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system PLoS One 7 2012 e28626
36. V.C. Primo, S. Marusic, and C.C. Franklin Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis Clin Exp Immunol 159 2010 327 337
37. R.J. Falk, R.S. Terrell, L.A. Charles, and J.C. Jennette Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro Proc Natl Acad Sci U S A 87 1990 4115 4119 (Pubitemid 20217992)
38. P. Hewins, M.D. Morgan, and N. Holden IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis Kidney Int 69 2006 605 615 (Pubitemid 43164456)
39. A. Schreiber, H. Xiao, and J.C. Jennette C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis J Am Soc Nephrol 20 2009 289 298
40. J. Yuan, S.J. Gou, and J. Huang C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis Arthritis Res Ther 14 2012 R140
41. L.A. Charles, M.L. Caldas, and R.J. Falk Antibodies against granule proteins activate neutrophils in vitro J Leukoc Biol 50 1991 539 546
42. A.P. Van Rossum, Y.M. van der Geld, P.C. Limburg, and C.G. Kallenberg Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils Kidney Int 68 2005 537 541 (Pubitemid 43323108)
43. L. Halbwachs-Mecarelli, G. Besson, and P. Lesavre Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool FEBS Lett 374 1995 29 33
44. V. Witko-Sarsat, P. Lesavre, and S. Lopez A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis J Am Soc Nephrol 10 1999 1224 1233 (Pubitemid 29246987)
45. A.A. Rarok, C.A. Stegeman, P.C. Limburg, and C.G. Kallenberg Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis J Am Soc Nephrol 13 2002 2232 2238 (Pubitemid 34925233)
46. A.P. Van Rossum, A.A. Rarok, and M.G. Huitema Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies J Leukoc Biol 76 2004 1162 1170 (Pubitemid 39602952)
47. N. Hu, J. Westra, and M.G. Huitema Coexpression of CD 177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody- associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils Arthritis Rheum 60 2009 1548 1557
48. U. Jenke, S. Rolle, and G. Dittmar Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation J Biol Chem 286 2011 7070 7081
49. C.F. Franssen, M.G. Huitema, and A.C. Muller Kobold In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis J Am Soc Nephrol 10 1999 1506 1515 (Pubitemid 29297525)
50. A.J. Porges, P.B. Redecha, and W.T. Kimberly Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamme RIIa J Immunol 153 1994 1271 1280
51. A.H. Mulder, P. Heeringa, and E. Brouwer Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process Clin Exp Immunol 98 1994 270 278 (Pubitemid 24336825)
52. A.H. Mulder, C.A. Stegeman, and C.G.M. Kallenberg Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA Clin Exp Immunol 101 1995 227 232
53. H.M. Dijstelbloem, R.H. Scheepers, and W.W. Oost Fc-gamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse Arthritis Rheum 42 1999 1823 1827 (Pubitemid 30257745)
54. M. Kocher, J.C. Edberg, H.B. Fleit, and R.P. Kimberly Antineutrophil cytoplasmic antibodies preferentially engage Fc gamma RIIIb on human neutrophils J Immunol 161 1998 6909 6914 (Pubitemid 28562237)
55. J.M. Kelley, P.A. Monach, and C. Ji IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis Proc Natl Acad Sci U S A 108 2011 20736 20741
56. A.A. Rarok, P.C. Limburg, and C.G. Kallenberg Neutrophil activating potential of antineutrophil cytoplasm autoantibodies J Leukoc Biol 74 2003 3 15 (Pubitemid 38040431)
57. R. Kettritz How anti-neutrophil cytoplasmic autoantibodies activate neutrophils Clin Exp Immunol 169 2012 220 228
58. J.M. Williams, T.R. Pettitt, and W. Powell Antineutrophil cytoplasm antibody-stimulated neutrophil adhesion depends on diacylglycerol kinase-catalyzed phosphatidic acid formation J Am Soc Nephrol 18 2007 1112 1120 (Pubitemid 46536897)
59. R. Kettritz, M. Choi, and W. Butt Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils J Am Soc Nephrol 13 2002 1740 1749 (Pubitemid 34700598)
60. A. Schreiber, S. Rolle, and L. Peripellittchenko Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis Kidney Int 77 2010 118 128
61. B.S. Van der Veen, M. Chen, and R. Muller Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo Ann Rheum Dis 70 2011 356 365
62. D. Reumaux, P.J. Vossebeld, D. Roos, and A.J. Verhoeven Effect of tumor necrosis factor-induced integrin activation of Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies Blood 86 1995 3189 3195
63. C.O. Savage, B.E. Pottinger, and G. Gaskin Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells Am J Pathol 141 1992 335 342
64. D.J. Radford, N.T. Luu, and P. Hewins Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells Arthritis Rheum 44 2001 2851 2861 (Pubitemid 34016205)
65. Y. Hong, D. Eleftheriou, and A.A. Hussain Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles J Am Soc Nephrol 23 2012 49 62
66. N.J. Holden, J.M. Williams, and M.D. Morgan ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant process Ann Rheum Dis 70 2011 2229 2233
67. K. Kessenbrock, M. Krumbhole, and U. Schönermarck Netting neutrophils in autoimmune small-vessel vasculitis Nat Med 15 2009 623 625
68. S. Sangaletti, C. Tripodo, and C. Chiodoni Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity Blood 120 2012 3007 3018
69. W.H. Schmitt, C. Heesen, and E. Csernok Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis Association with disease activity Arthritis Rheum 35 1992 1088 1096
70. C.A. Stegeman, J.W. Tervaert, M.G. Huitema, and C.G. Kallenberg Serum markers of T cell activation in relapses of Wegener's granulomatosis Clin Exp Immunol 91 1993 415 420 (Pubitemid 23074146)
71. E.R. Popa, C.A. Stegeman, and N.A. Bos Differential B- and T-cell activation in Wegener's granulomatosis J Allergy Clin Immunol 103 1999 885 894 (Pubitemid 29297593)
72. M.D. Morgan, A. Pachnio, and J. Begum CD4+CD28- T-cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality Arthritis Rheum 63 2011 2127 2137
73. E. Brouwer, C.A. Stegeman, and M.G. Huitema T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis Clin Exp Immunol 98 1994 448 453 (Pubitemid 24374730)
74. W.H. Abdulahad, Y.M. van der Geld, C.A. Stegeman, and C.G. Kallenberg Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis Kidney Int 70 2006 938 947 (Pubitemid 44285972)
75. W.H. Abdulahad, C.G. Kallenberg, P.C. Limburg, and C.A. Stegeman Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 60 2009 2830 2838
76. W.H. Abdulahad, N. Lepse, and H. Tadema Increased frequency of circulating follicular helper T-cells in patients with granulomatosis with polyangiitis Clin Exp Immunol 164 suppl 1 2011 149
77. W.H. Abdulahad, C.A. Stegeman, P.C. Limburg, and C.G. Kallenberg Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission Arthritis Rheum 58 2008 2196 2205 (Pubitemid 351988114)
78. E. Nogueira, S. Hamour, and D. Sawant Serum IL-17 and IL-23 levels and autoantigenic-specific Th17 cells are elevated in patients with ANCA-associated vasculitis Nephrol Dial Transplant 25 2010 2209 2217
79. W.H. Abdulahad, C.A. Stegeman, and Y.M. van der Geld Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission Arthritis Rheum 56 2007 2080 2091 (Pubitemid 47110408)
80. M.D. Morgan, C.J. Day, and K.P. Piper Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells Immunology 130 2010 64 73
81. M. Rimbert, M. Hamidou, and C. Brandeau Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis PLoS One 6 2011 e18734
82. K.M. Chavele, D. Shuckla, and T. Keteepe-Arachi Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody associated vasculitis: the role of Treg cells and tryptophan degradation Arthritis Rheum 62 2010 1539 1548
83. C. Mauri, and A. Bosma Immune regulatory function of B cells Annu Rev Immunol 30 2012 221 241
84. S.L. Hogan, K.K. Saterly, and M.A. Dooley Silical exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis J Am Soc Nephrol 12 2001 134 142 (Pubitemid 32056798)
85. S.L. Hogan, G.S. Cooper, and D.A. Savitz Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study Clin J Am Soc Nephrol 2 2007 290 299
86. C.A. Stegeman, J.W. Tervaert, and W.J. Sluiter Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis Ann Intern Med 120 1994 12 17 (Pubitemid 24011495)
87. E.R. Popa, C.A. Stegeman, C.G. Kallenberg, and J.W. Tervaert Staphylococcus aureus and Wegener's granulomatosis Arthritis Res 4 2002 77 79
88. E.R. Popa, C.A. Stegeman, and W.H. Abdulahad Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis Rheumatology (Oxford) 46 2007 1029 1033 (Pubitemid 47062516)
89. H. Tadema, W.H. Abdulahad, and C.A. Stegeman Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis PLoS One 6 2011 e24315
90. H. Tadema, W.H. Abdulahad, and N. Lepse Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission Rheumatology (Oxford) 50 2011 689 696
91. P.R. Hurtado, L. Jeffs, and J. Nitschk CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis BMC Immunol 9 2008 34
92. W.F. Pendergraft III, G.A. Preston, and R.R. Shah Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3 Nat Med 10 2004 72 79 (Pubitemid 38524701)
93. H. Tadema, C.G. Kallenberg, C.A. Stegeman, and P. Heeringa Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA associated vasculitis PLoS One 6 2011 e17972
94. R. Kain, K. Matsui, and M. Exner A novel class of autoantigens in anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells J Exp Med 181 1995 585 597
95. R. Kain, M. Exner, and R. Brandes Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis Nat Med 14 2008 1088 1096
96. R. Kain, H. Tadema, and E.F. McKinney High prevalence of autoantibodies to hLamp-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis J Am Soc Nephrol 23 2012 556 566
97. A.J. Roth, M.C. Brown, and R.N. Smith Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis J Am Soc Nephrol 23 2012 545 555
98. R.M. Smith, R.B. Jones, and D.R. Jayne Progress in treatment of ANCA-associated vasculitis Arthritis Res Ther 14 2012 210
99. C.G.M. Kallenberg Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis? Ann Rheum Dis 72 Suppl 2 2013 ii62 ii65
100. D.R. Jayne, G. Gaskin, and N. Rasmussen Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2007 2180 2188 (Pubitemid 47041083)
101. J.H. Stone, P.A. Merkel, and R. Spiera Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 2010 221 232
102. R.B. Jones, J.W. Tervaert, and T. Hauser Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis N Engl J Med 363 2010 211 220
103. R. Cartin-Ceba, J.M. Golbin, and K.A. Keogh Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center Arthritis Rheum 64 2012 3770 3778